首页 > 最新文献

Journal of Magnetic Resonance Imaging最新文献

英文 中文
Development and Deployment of a Machine Learning Model to Triage the Use of Prostate MRI (ProMT-ML) in Patients With Suspected Prostate Cancer. 一种机器学习模型的开发和部署,用于前列腺MRI (ProMT-ML)在疑似前列腺癌患者中的分类使用。
IF 3.5 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-04 DOI: 10.1002/jmri.70162
Jesse Persily, Hersh Chandarana, Angela Tong, Rajesh Ranganath, Samir Taneja, Madhur Nayan

Background: Access to prostate MRI remains limited due to resource constraints and the need for expert interpretation.

Purpose: To develop machine learning (ML) models that enable risk-based triage for prostate MRI (ProMT-ML) in the evaluation of prostate cancer.

Study type: Retrospective and prospective.

Population: A total of 11,879 retrospective MRI scans for suspected prostate cancer from a multi-hospital health system, divided into training (N = 9504) and test (N = 2375) sets. A total of 4551 records for prospective validation.

Field strength/sequence: 1.5T and 3T/Turbo-spin echo T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE).

Assessment: Prostate Imaging Reporting and Data System (PI-RADS) scores were retrieved from MRI reports. The Boruta algorithm was used to select final input features from candidate features. Two models were developed using supervised ML to estimate the likelihood of an abnormal MRI, defined as PI-RADS ≥ 3: Model A (with prostate volume) and Model B (without prostate volume). Models were compared to PSA. Prostate biopsy pathology was assessed to evaluate potential clinical impact.

Statistical tests: Area under the receiver operating characteristic curve (AUC) was the primary performance metric.

Results: A total of 5580 (46.9%) subjects had a PI-RADS score ≥ 3. After feature selection, Model A included age, PSA, body mass index, and prostate volume, while Model B included age, PSA, body mass index, and systolic blood pressure. Both models A (AUC 0.711) and B (AUC 0.616) significantly outperformed PSA (AUC 0.593). Compared to PSA threshold > 4 ng/mL, Model A demonstrated significantly improved specificity (28.3% vs. 21.9%) and no significant difference in sensitivity (89.0% vs. 86.7%). Among false negatives (Model A: 8.0% (62/776); Model B: 16.8% (130/776)), most (Model A: 87%; Model B: 69%) had benign or clinically insignificant disease on biopsy. On prospective validation, both versions of ProMT-ML significantly outperformed PSA.

Data conclusion: ProMT-ML provides personalized risk estimates of abnormal prostate MRI and can support triage of this test.

Level of evidence: 2:

Technical efficacy: Stage 4.

背景:由于资源限制和专家解释的需要,前列腺MRI的使用仍然有限。目的:开发机器学习(ML)模型,使前列腺MRI (ProMT-ML)评估前列腺癌的风险分类成为可能。研究类型:回顾性和前瞻性。人群:来自多医院卫生系统的11,879例疑似前列腺癌的回顾性MRI扫描,分为训练组(N = 9504)和测试组(N = 2375)。总共4551条记录用于前瞻性验证。场强/序列:1.5T、3T/涡旋回波t2加权成像(T2WI)、弥散加权成像(DWI)、动态对比增强(DCE)。评估:从MRI报告中检索前列腺成像报告和数据系统(PI-RADS)评分。使用Boruta算法从候选特征中选择最终输入特征。使用有监督的ML建立了两个模型来估计异常MRI的可能性,定义为PI-RADS≥3:模型A(有前列腺体积)和模型B(无前列腺体积)。将模型与PSA进行比较。评估前列腺活检病理以评估潜在的临床影响。统计检验:受试者工作特征曲线下面积(AUC)为主要性能指标。结果:共有5580例(46.9%)受试者PI-RADS评分≥3分。特征选择后,模型A包括年龄、PSA、体质指数、前列腺体积,模型B包括年龄、PSA、体质指数、收缩压。模型A (AUC 0.711)和模型B (AUC 0.616)均显著优于PSA (AUC 0.593)。与PSA阈值bbbb4 ng/mL相比,A模型特异性显著提高(28.3% vs. 21.9%),敏感性无显著差异(89.0% vs. 86.7%)。假阴性中(模型A: 8.0% (62/776);B模型:16.8%(130/776)),大多数(A模型:87%;B模型:69%)活检为良性或临床无关紧要的疾病。在前瞻性验证中,两种版本的ProMT-ML都明显优于PSA。数据结论:ProMT-ML提供了前列腺MRI异常的个性化风险评估,并可支持该测试的分诊。证据等级:2;技术功效:第4阶段。
{"title":"Development and Deployment of a Machine Learning Model to Triage the Use of Prostate MRI (ProMT-ML) in Patients With Suspected Prostate Cancer.","authors":"Jesse Persily, Hersh Chandarana, Angela Tong, Rajesh Ranganath, Samir Taneja, Madhur Nayan","doi":"10.1002/jmri.70162","DOIUrl":"https://doi.org/10.1002/jmri.70162","url":null,"abstract":"<p><strong>Background: </strong>Access to prostate MRI remains limited due to resource constraints and the need for expert interpretation.</p><p><strong>Purpose: </strong>To develop machine learning (ML) models that enable risk-based triage for prostate MRI (ProMT-ML) in the evaluation of prostate cancer.</p><p><strong>Study type: </strong>Retrospective and prospective.</p><p><strong>Population: </strong>A total of 11,879 retrospective MRI scans for suspected prostate cancer from a multi-hospital health system, divided into training (N = 9504) and test (N = 2375) sets. A total of 4551 records for prospective validation.</p><p><strong>Field strength/sequence: </strong>1.5T and 3T/Turbo-spin echo T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and dynamic contrast-enhanced (DCE).</p><p><strong>Assessment: </strong>Prostate Imaging Reporting and Data System (PI-RADS) scores were retrieved from MRI reports. The Boruta algorithm was used to select final input features from candidate features. Two models were developed using supervised ML to estimate the likelihood of an abnormal MRI, defined as PI-RADS ≥ 3: Model A (with prostate volume) and Model B (without prostate volume). Models were compared to PSA. Prostate biopsy pathology was assessed to evaluate potential clinical impact.</p><p><strong>Statistical tests: </strong>Area under the receiver operating characteristic curve (AUC) was the primary performance metric.</p><p><strong>Results: </strong>A total of 5580 (46.9%) subjects had a PI-RADS score ≥ 3. After feature selection, Model A included age, PSA, body mass index, and prostate volume, while Model B included age, PSA, body mass index, and systolic blood pressure. Both models A (AUC 0.711) and B (AUC 0.616) significantly outperformed PSA (AUC 0.593). Compared to PSA threshold > 4 ng/mL, Model A demonstrated significantly improved specificity (28.3% vs. 21.9%) and no significant difference in sensitivity (89.0% vs. 86.7%). Among false negatives (Model A: 8.0% (62/776); Model B: 16.8% (130/776)), most (Model A: 87%; Model B: 69%) had benign or clinically insignificant disease on biopsy. On prospective validation, both versions of ProMT-ML significantly outperformed PSA.</p><p><strong>Data conclusion: </strong>ProMT-ML provides personalized risk estimates of abnormal prostate MRI and can support triage of this test.</p><p><strong>Level of evidence: 2: </strong></p><p><strong>Technical efficacy: </strong>Stage 4.</p>","PeriodicalId":16140,"journal":{"name":"Journal of Magnetic Resonance Imaging","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145438247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiotoxicity and Neurotoxicity in Breast Cancer Patients: Is It Time for MRI to Connect the Dots? 乳腺癌患者的心脏毒性和神经毒性:是时候用MRI连接这些点了吗?
IF 3.5 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-11-02 DOI: 10.1002/jmri.70165
Jose de Arimateia Batista Araujo-Filho, Almir G V Bitencourt
{"title":"Cardiotoxicity and Neurotoxicity in Breast Cancer Patients: Is It Time for MRI to Connect the Dots?","authors":"Jose de Arimateia Batista Araujo-Filho, Almir G V Bitencourt","doi":"10.1002/jmri.70165","DOIUrl":"https://doi.org/10.1002/jmri.70165","url":null,"abstract":"","PeriodicalId":16140,"journal":{"name":"Journal of Magnetic Resonance Imaging","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145431644","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial for "Betanin-Based Contrast Agents for MRI: A Preliminary Experimental Study". “以甜菜素为基础的MRI造影剂:初步实验研究”的社论。
IF 3.5 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-31 DOI: 10.1002/jmri.70161
Olivier Clement, Anne-Laure Gaultier
{"title":"Editorial for \"Betanin-Based Contrast Agents for MRI: A Preliminary Experimental Study\".","authors":"Olivier Clement, Anne-Laure Gaultier","doi":"10.1002/jmri.70161","DOIUrl":"https://doi.org/10.1002/jmri.70161","url":null,"abstract":"","PeriodicalId":16140,"journal":{"name":"Journal of Magnetic Resonance Imaging","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacological MRI: Utility in Understanding Drug Mechanisms in Psychiatric Disorders 药理学MRI:在理解精神疾病药物机制中的应用。
IF 3.5 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-29 DOI: 10.1002/jmri.70160
Christin Y. Sander, Tudor M. Ionescu, Mitul A. Mehta, Ottavia Dipasquale, Anouk Schrantee

Pharmacological MRI (pharmaMRI) has emerged as a powerful tool to study how psychoactive drugs affect brain function and to uncover mechanisms of drug action in psychiatric disorders. This review provides an overview of key techniques used in pharmaMRI, including BOLD-fMRI, arterial spin labeling (ASL), and cerebral blood volume (CBV) mapping, and how they have advanced our understanding of drug-induced changes in neural activity and connectivity. We present key advances in both preclinical and clinical pharmaMRI, highlighting its value in elucidating drug mechanisms and informing psychiatric treatment development. In preclinical studies, pharmaMRI benefits from optimized hardware, the use of contrast agents such as iron oxide nanoparticles, and precise experimental control, including invasive neuromodulation techniques (e.g., opto- and chemogenetics). These studies offer critical mechanistic insights into receptor-specific and circuit-level drug effects, supporting hypothesis-driven translation to humans. Clinically, pharmaMRI has advanced our understanding of how compounds, such as antidepressants, antipsychotics, and stimulants, affect large-scale brain networks and offers potential for modeling psychiatric phenotypes and predicting treatment response. Furthermore, pharmaMRI can serve as a biomarker for target engagement and refine dose selection in early-phase trials. Despite growing interest, clinical adoption remains limited. Systematic use of both preclinical and clinical pharmaMRI could accelerate drug development, support precision psychiatry, and deepen understanding of treatment mechanisms. Finally, open science practices and large-scale datasets can help contextualize drug effects within broader neural and molecular frameworks. While these developments present some challenges, they position pharmaMRI as a critical bridge between molecular mechanisms and systems-level brain function in psychiatry.

Evidence Level

N/A.

Technical Efficacy

Stage 1.

药理学MRI (pharmacamri)已成为研究精神活性药物如何影响脑功能和揭示精神疾病药物作用机制的有力工具。本文综述了用于pharmri的关键技术,包括BOLD-fMRI、动脉自旋标记(ASL)和脑血容量(CBV)制图,以及它们如何促进我们对药物诱导的神经活动和连通性变化的理解。我们介绍了临床前和临床药物研究的关键进展,强调了其在阐明药物机制和为精神病学治疗发展提供信息方面的价值。在临床前研究中,pharmaMRI受益于优化的硬件、氧化铁纳米颗粒等造影剂的使用和精确的实验控制,包括侵入性神经调节技术(如光学和化学遗传学)。这些研究为受体特异性和回路水平的药物作用提供了关键的机制见解,支持假设驱动的人类翻译。在临床上,pharmaMRI提高了我们对化合物(如抗抑郁药、抗精神病药和兴奋剂)如何影响大规模大脑网络的理解,并为精神病学表型建模和预测治疗反应提供了潜力。此外,在早期试验中,pharmaMRI可以作为靶标结合的生物标志物,并优化剂量选择。尽管越来越多的人感兴趣,临床应用仍然有限。系统地使用临床前和临床药物研究可以加速药物开发,支持精确精神病学,并加深对治疗机制的理解。最后,开放科学实践和大规模数据集可以帮助在更广泛的神经和分子框架内了解药物效应。虽然这些发展带来了一些挑战,但它们将药物研究定位为精神病学分子机制和系统级脑功能之间的关键桥梁。证据级别:无。技术功效:第一阶段。
{"title":"Pharmacological MRI: Utility in Understanding Drug Mechanisms in Psychiatric Disorders","authors":"Christin Y. Sander,&nbsp;Tudor M. Ionescu,&nbsp;Mitul A. Mehta,&nbsp;Ottavia Dipasquale,&nbsp;Anouk Schrantee","doi":"10.1002/jmri.70160","DOIUrl":"10.1002/jmri.70160","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Pharmacological MRI (pharmaMRI) has emerged as a powerful tool to study how psychoactive drugs affect brain function and to uncover mechanisms of drug action in psychiatric disorders. This review provides an overview of key techniques used in pharmaMRI, including BOLD-fMRI, arterial spin labeling (ASL), and cerebral blood volume (CBV) mapping, and how they have advanced our understanding of drug-induced changes in neural activity and connectivity. We present key advances in both preclinical and clinical pharmaMRI, highlighting its value in elucidating drug mechanisms and informing psychiatric treatment development. In preclinical studies, pharmaMRI benefits from optimized hardware, the use of contrast agents such as iron oxide nanoparticles, and precise experimental control, including invasive neuromodulation techniques (e.g., opto- and chemogenetics). These studies offer critical mechanistic insights into receptor-specific and circuit-level drug effects, supporting hypothesis-driven translation to humans. Clinically, pharmaMRI has advanced our understanding of how compounds, such as antidepressants, antipsychotics, and stimulants, affect large-scale brain networks and offers potential for modeling psychiatric phenotypes and predicting treatment response. Furthermore, pharmaMRI can serve as a biomarker for target engagement and refine dose selection in early-phase trials. Despite growing interest, clinical adoption remains limited. Systematic use of both preclinical and clinical pharmaMRI could accelerate drug development, support precision psychiatry, and deepen understanding of treatment mechanisms. Finally, open science practices and large-scale datasets can help contextualize drug effects within broader neural and molecular frameworks. While these developments present some challenges, they position pharmaMRI as a critical bridge between molecular mechanisms and systems-level brain function in psychiatry.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Evidence Level</h3>\u0000 \u0000 <p>N/A.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Technical Efficacy</h3>\u0000 \u0000 <p>Stage 1.</p>\u0000 </section>\u0000 </div>","PeriodicalId":16140,"journal":{"name":"Journal of Magnetic Resonance Imaging","volume":"63 2","pages":"346-363"},"PeriodicalIF":3.5,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12811002/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145390314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
High-Fidelity T2 Relaxometry of the Developing Fetal Brain Using an 8-Second Single-Shot Multiple Overlapping-Echo Detachment (MOLED) MRI Technique. 利用8秒单镜头多重重叠回声分离(MOLED) MRI技术对发育中的胎儿大脑进行高保真T2松弛测量。
IF 3.5 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-29 DOI: 10.1002/jmri.70164
Nuowei Ge, Qinqin Yang, Chenyu Yan, Fei Wu, Yong Zhang, Dan Wu, Zhong Chen, Jianhui Zhong, Congbo Cai, Jianfeng Bao, Shuhui Cai

Background: Although quantitative MRI can provide objective biomarkers for brain maturation assessment, unpredictable fetal movement limits its application on fetuses.

Purpose: To evaluate single-shot multiple overlapping-echo detachment (MOLED) imaging for fetal brain T2 relaxometry and to quantify fetal brain maturation using T2 relaxation time.

Study type: Phantom and prospective in vivo assessment.

Subjects: T2 phantom and 52 fetuses (mean gestational age [GA], 30.94 ± 3.62 weeks; range, 23-37 weeks).

Field strength/sequence: 3T; half-Fourier acquisition single-shot turbo spin-echo (HASTE) and MOLED sequences.

Assessment: The accuracy, motion robustness, and repeatability of 8-s MOLED T2 relaxometry were assessed using motion-free and motion phantom acquisitions. In 15 fetuses, the MOLED scan was repeated within 5 min to assess scan-rescan repeatability. Regional T2 values were determined in fetal white matter (WM), deep gray matter (dGM) and brainstem, and their changes with GA evaluated.

Statistical tests: Bland-Altman analysis, linear regression analysis (Pearson correlation coefficient, r), coefficient of variation, repeated-measures analysis of variance, and intraclass correlation coefficient. p < 0.05 was considered statistically significant.

Results: Motion-free and motion phantom acquisitions demonstrated that MOLED T2 significantly agreed with reference T2 (r = 0.99). In vivo studies reported mean T2 values for all fetuses (WM, 215.20 ms; dGM, 145.82 ms; brainstem, 125.80 ms). Scan-rescan acquisitions showed non-significant mean T2 differences (bias < 1%; limits of agreement, -8.51% to +7.78%). Regional T2 values showed significant negative correlations (r, -0.85 to -0.60) with GA. The brainstem exhibited a significantly higher rate of GA-related T2 change (3.43 ms per week) than WM and dGM (2.19 and 2.89 ms per week, respectively).

Data conclusion: MOLED imaging appears to allow motion-robust, clinically feasible, and highly repeatable T2 measurements for the whole fetal brain in 8 s. Regional differences in T2 values and age-related T2 changes demonstrate its potential for quantifying in utero brain maturation.

Evidence level: 2.

Technical efficacy: Stage 1.

背景:虽然定量MRI可以为脑成熟评估提供客观的生物标志物,但不可预测的胎儿运动限制了其在胎儿上的应用。目的:评价单次多重重叠回声脱离(MOLED)成像对胎儿脑T2松弛测量的价值,并利用T2松弛时间定量胎儿脑成熟程度。研究类型:幻影和前瞻性体内评估。研究对象:T2幻影和52例胎儿(平均胎龄[GA], 30.94±3.62周;范围:23-37周)。场强/序列:3T;半傅立叶采集单次涡轮自旋回波(HASTE)和MOLED序列。评估:8-s MOLED T2松弛测量的准确性、运动稳健性和可重复性通过无运动和运动幻象采集进行评估。在15个胎儿中,在5分钟内重复MOLED扫描以评估扫描-扫描的重复性。测定胎儿白质(WM)、深灰质(dGM)和脑干的区域T2值,并评价其随GA的变化。统计检验:Bland-Altman分析、线性回归分析(Pearson相关系数,r)、变异系数、重复测量方差分析、类内相关系数。p结果:无运动和运动幻影显示MOLED T2与参考T2显著一致(r = 0.99)。体内研究报告了所有胎儿的平均T2值(WM, 215.20 ms; dGM, 145.82 ms;脑干,125.80 ms)。数据结论:MOLED成像似乎可以在8秒内对整个胎儿大脑进行运动稳健、临床可行和高度可重复的T2测量。T2值的区域差异和年龄相关的T2变化表明其在子宫内脑成熟的量化潜力。证据等级:2。技术功效:第一阶段。
{"title":"High-Fidelity T2 Relaxometry of the Developing Fetal Brain Using an 8-Second Single-Shot Multiple Overlapping-Echo Detachment (MOLED) MRI Technique.","authors":"Nuowei Ge, Qinqin Yang, Chenyu Yan, Fei Wu, Yong Zhang, Dan Wu, Zhong Chen, Jianhui Zhong, Congbo Cai, Jianfeng Bao, Shuhui Cai","doi":"10.1002/jmri.70164","DOIUrl":"https://doi.org/10.1002/jmri.70164","url":null,"abstract":"<p><strong>Background: </strong>Although quantitative MRI can provide objective biomarkers for brain maturation assessment, unpredictable fetal movement limits its application on fetuses.</p><p><strong>Purpose: </strong>To evaluate single-shot multiple overlapping-echo detachment (MOLED) imaging for fetal brain T2 relaxometry and to quantify fetal brain maturation using T2 relaxation time.</p><p><strong>Study type: </strong>Phantom and prospective in vivo assessment.</p><p><strong>Subjects: </strong>T2 phantom and 52 fetuses (mean gestational age [GA], 30.94 ± 3.62 weeks; range, 23-37 weeks).</p><p><strong>Field strength/sequence: </strong>3T; half-Fourier acquisition single-shot turbo spin-echo (HASTE) and MOLED sequences.</p><p><strong>Assessment: </strong>The accuracy, motion robustness, and repeatability of 8-s MOLED T2 relaxometry were assessed using motion-free and motion phantom acquisitions. In 15 fetuses, the MOLED scan was repeated within 5 min to assess scan-rescan repeatability. Regional T2 values were determined in fetal white matter (WM), deep gray matter (dGM) and brainstem, and their changes with GA evaluated.</p><p><strong>Statistical tests: </strong>Bland-Altman analysis, linear regression analysis (Pearson correlation coefficient, r), coefficient of variation, repeated-measures analysis of variance, and intraclass correlation coefficient. p < 0.05 was considered statistically significant.</p><p><strong>Results: </strong>Motion-free and motion phantom acquisitions demonstrated that MOLED T2 significantly agreed with reference T2 (r = 0.99). In vivo studies reported mean T2 values for all fetuses (WM, 215.20 ms; dGM, 145.82 ms; brainstem, 125.80 ms). Scan-rescan acquisitions showed non-significant mean T2 differences (bias < 1%; limits of agreement, -8.51% to +7.78%). Regional T2 values showed significant negative correlations (r, -0.85 to -0.60) with GA. The brainstem exhibited a significantly higher rate of GA-related T2 change (3.43 ms per week) than WM and dGM (2.19 and 2.89 ms per week, respectively).</p><p><strong>Data conclusion: </strong>MOLED imaging appears to allow motion-robust, clinically feasible, and highly repeatable T2 measurements for the whole fetal brain in 8 s. Regional differences in T2 values and age-related T2 changes demonstrate its potential for quantifying in utero brain maturation.</p><p><strong>Evidence level: </strong>2.</p><p><strong>Technical efficacy: </strong>Stage 1.</p>","PeriodicalId":16140,"journal":{"name":"Journal of Magnetic Resonance Imaging","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145390254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial for "Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: Long-Term Follow-Up of Deformations and Hemodynamics". 《肥厚性梗阻性心肌病酒精性室间隔消融术:变形和血流动力学的长期随访》的社论。
IF 3.5 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-29 DOI: 10.1002/jmri.70163
David Marlevi, Anna Damlin, Alexander Fyrdahl
{"title":"Editorial for \"Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: Long-Term Follow-Up of Deformations and Hemodynamics\".","authors":"David Marlevi, Anna Damlin, Alexander Fyrdahl","doi":"10.1002/jmri.70163","DOIUrl":"https://doi.org/10.1002/jmri.70163","url":null,"abstract":"","PeriodicalId":16140,"journal":{"name":"Journal of Magnetic Resonance Imaging","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145390320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fat-Corrected Non-Gaussian Diffusion MRI for Liver Fibrosis Assessment in Metabolic Dysfunction-Associated Steatotic Liver Disease 脂肪校正非高斯扩散MRI对代谢功能障碍相关脂肪变性肝病肝纤维化的评估。
IF 3.5 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-24 DOI: 10.1002/jmri.70148
Omaïma Saïd, Sabrina Doblas, Valérie Paradis, Pierre Bedossa, Dominique Valla, Cédric Laouénan, Laurent Castera, Bernard E. Van Beers, Philippe Garteiser
<div> <section> <h3> Background</h3> <p>In patients with metabolic dysfunction-associated steatotic liver disease (MASLD), non-Gaussian diffusion—weighted imaging (DWI) has been proposed for the diagnosis of liver fibrosis, but its measurement is partially confounded by steatosis. We therefore asked whether a fat-corrected approach could improve fibrosis assessment.</p> </section> <section> <h3> Purpose</h3> <p>To evaluate the diagnostic performance of non-Gaussian diffusion coefficients for the assessment of fibrosis in MASLD patients with a method accounting for intravoxel fat.</p> </section> <section> <h3> Study Type</h3> <p>Prospective single-center cross-sectional study.</p> </section> <section> <h3> Population</h3> <p>A total of 289 participants with Type 2 diabetes, hepatic steatosis, and elevated aminotransferases were enrolled from October 2018 to June 2021. Among them, 222 participants (mean age 59 ± 10 years; 149 men) underwent liver biopsy and MRI and were included in the final analysis.</p> </section> <section> <h3> Field Strength/Sequence</h3> <p>3 T, DWI using spin-echo echo-planar imaging, MR elastography (MRE) using gradient echo sequence and fat fraction imaging using a multiple gradient echoes sequence.</p> </section> <section> <h3> Assessment</h3> <p>Diffusion coefficients were estimated using two non-Gaussian models: a shifted apparent diffusion coefficient (sADC) and a non-linear least squares fit (ngADC), both computed without and with intravoxel fat correction (corr) using fat fraction on PDFF. Fibrosis was staged histologically. Quantitative parameters were compared across fibrosis stages. Diagnostic performance for F0 versus ≥ F1 was evaluated and compared to liver stiffness on MRE.</p> </section> <section> <h3> Statistical Tests</h3> <p>Group comparisons used Kruskal-Wallis tests (<i>α</i> = 0.05), and diagnostic performance was assessed via receiver operating characteristic (ROC) curve analysis with 95% confidence intervals, with <i>p</i> < 0.05 considered statistically significant.</p> </section> <section> <h3> Results</h3> <p>ngADC<sub>corr</sub> was significantly different between fibrosis stages (Kruskal–Wallis <i
背景:在代谢功能障碍相关的脂肪变性肝病(MASLD)患者中,非高斯弥散加权成像(DWI)已被提议用于肝纤维化的诊断,但其测量部分与脂肪变性混淆。因此,我们询问脂肪校正方法是否可以改善纤维化评估。目的:评价非高斯扩散系数在计算体内脂肪的方法中评估MASLD患者纤维化的诊断性能。研究类型:前瞻性单中心横断面研究。人群:2018年10月至2021年6月,共有289名患有2型糖尿病、肝脂肪变性和转氨酶升高的参与者入组。其中222例(平均年龄59±10岁,男性149例)行肝活检和MRI纳入最终分析。场强/序列:3t, DWI使用自旋回波回波平面成像,MR弹性成像(MRE)使用梯度回波序列,脂肪部分成像使用多重梯度回波序列。评估:扩散系数使用两种非高斯模型估计:移位表观扩散系数(sADC)和非线性最小二乘拟合(ngADC),两者都使用PDFF上的脂肪分数在没有和具有体内脂肪校正(corr)的情况下计算。纤维化病理分期。比较各纤维化阶段的定量参数。评估F0和≥F1的诊断性能,并比较MRE上的肝脏僵硬度。统计学检验:组间比较采用Kruskal-Wallis检验(α = 0.05),诊断效能采用受试者工作特征(ROC)曲线分析,95%可信区间为p。结果:ngADCcorr在纤维化分期间差异有统计学意义(Kruskal-Wallis p corr和僵硬度(AUC = 0.66, 95% CI: [0.59, 0.7], p)。基于拟合的非高斯DWI与脂肪校正可能具有与MRE相似的诊断准确性,用于检测MASLD患者的纤维化。证据等级:3。技术功效:第二阶段。
{"title":"Fat-Corrected Non-Gaussian Diffusion MRI for Liver Fibrosis Assessment in Metabolic Dysfunction-Associated Steatotic Liver Disease","authors":"Omaïma Saïd,&nbsp;Sabrina Doblas,&nbsp;Valérie Paradis,&nbsp;Pierre Bedossa,&nbsp;Dominique Valla,&nbsp;Cédric Laouénan,&nbsp;Laurent Castera,&nbsp;Bernard E. Van Beers,&nbsp;Philippe Garteiser","doi":"10.1002/jmri.70148","DOIUrl":"10.1002/jmri.70148","url":null,"abstract":"&lt;div&gt;\u0000 \u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Background&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;In patients with metabolic dysfunction-associated steatotic liver disease (MASLD), non-Gaussian diffusion—weighted imaging (DWI) has been proposed for the diagnosis of liver fibrosis, but its measurement is partially confounded by steatosis. We therefore asked whether a fat-corrected approach could improve fibrosis assessment.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Purpose&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;To evaluate the diagnostic performance of non-Gaussian diffusion coefficients for the assessment of fibrosis in MASLD patients with a method accounting for intravoxel fat.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Study Type&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Prospective single-center cross-sectional study.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Population&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;A total of 289 participants with Type 2 diabetes, hepatic steatosis, and elevated aminotransferases were enrolled from October 2018 to June 2021. Among them, 222 participants (mean age 59 ± 10 years; 149 men) underwent liver biopsy and MRI and were included in the final analysis.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Field Strength/Sequence&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;3 T, DWI using spin-echo echo-planar imaging, MR elastography (MRE) using gradient echo sequence and fat fraction imaging using a multiple gradient echoes sequence.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Assessment&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Diffusion coefficients were estimated using two non-Gaussian models: a shifted apparent diffusion coefficient (sADC) and a non-linear least squares fit (ngADC), both computed without and with intravoxel fat correction (corr) using fat fraction on PDFF. Fibrosis was staged histologically. Quantitative parameters were compared across fibrosis stages. Diagnostic performance for F0 versus ≥ F1 was evaluated and compared to liver stiffness on MRE.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Statistical Tests&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;Group comparisons used Kruskal-Wallis tests (&lt;i&gt;α&lt;/i&gt; = 0.05), and diagnostic performance was assessed via receiver operating characteristic (ROC) curve analysis with 95% confidence intervals, with &lt;i&gt;p&lt;/i&gt; &lt; 0.05 considered statistically significant.&lt;/p&gt;\u0000 &lt;/section&gt;\u0000 \u0000 &lt;section&gt;\u0000 \u0000 &lt;h3&gt; Results&lt;/h3&gt;\u0000 \u0000 &lt;p&gt;ngADC&lt;sub&gt;corr&lt;/sub&gt; was significantly different between fibrosis stages (Kruskal–Wallis &lt;i","PeriodicalId":16140,"journal":{"name":"Journal of Magnetic Resonance Imaging","volume":"63 2","pages":"497-507"},"PeriodicalIF":3.5,"publicationDate":"2025-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12811005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145355084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial for “Association of Blood-Brain Barrier Function With Disease Activity and Cognitive Function in Systemic Lupus Erythematosus Patients: A Multicenter Cross-Sectional Study” 《系统性红斑狼疮患者血脑屏障功能与疾病活动性和认知功能的关联:一项多中心横断面研究》的社论。
IF 3.5 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-23 DOI: 10.1002/jmri.70144
Alexandre Coimbra
{"title":"Editorial for “Association of Blood-Brain Barrier Function With Disease Activity and Cognitive Function in Systemic Lupus Erythematosus Patients: A Multicenter Cross-Sectional Study”","authors":"Alexandre Coimbra","doi":"10.1002/jmri.70144","DOIUrl":"10.1002/jmri.70144","url":null,"abstract":"","PeriodicalId":16140,"journal":{"name":"Journal of Magnetic Resonance Imaging","volume":"63 2","pages":"607-608"},"PeriodicalIF":3.5,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145355034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: Long-Term Follow-Up of Deformations and Hemodynamics. 肥厚性梗阻性心肌病的酒精室间隔消融术:变形和血流动力学的长期随访。
IF 3.5 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-23 DOI: 10.1002/jmri.70156
Kenichiro Suwa, Kazuto Ohno, Terumori Satoh, Ryota Sato, Keisuke Iguchi, Yuichiro Maekawa

Background: A detailed evaluation of hemodynamics, supportive morphology, and deformation may help uncover the pathophysiology of hypertrophic obstructive cardiomyopathy (HOCM) and the changes wrought by alcohol septal ablation (ASA).

Purpose: To investigate the global cardiac volume, myocardial deformation, and hemodynamic characteristics before and during long-term follow-up after ASA in patients with HOCM.

Study type: Retrospective.

Subjects: Twenty-three patients (68.1 ± 8.6 years, 21.7% male) with HOCM who underwent MRI before and after ASA.

Field strength/sequence: A 3T, Two-dimensional fast imaging employing steady-state acquisition, inversion recovery-prepared fast gradient echo sequences, and cine and time-resolved three-dimensional cine phase-contrast (4D flow) MRI.

Assessment: Global left ventricular (LV) volume by cine, peak strain, and strain rate by myocardial feature-tracking MRI, and hemodynamic characteristics by 4D flow MRI.

Statistical tests: Paired t-test and Wilcoxon signed-rank test compared normally and nonnormally distributed data, respectively. Chi-squared or Fisher's exact tests were used to compare categorical data, as appropriate. Pearson's or Spearman's correlation coefficient evaluated the correlations. Statistical significance was set at q ≤ 0.10 or p < 0.05.

Results: In LV long-axis images, the global radial strain increased significantly (16.6% ± 5.8% vs. 20.1% ± 6.8%), whereas the global longitudinal strain decreased significantly after ASA (-10.5% ± 3.2% vs. -12.1% ± 3.5%). The diastolic LV anterior vortex area increased significantly after ASA (2256.1 [703.6, 4038.4] vs. 3826.1 [1914.3, 4820.1] mm2). Multiplication of the LV end-diastolic volume index, global circumferential strain, and diastolic radial peak strain rate in LV long-axis images revealed a significant correlation with the diastolic LV anterior vortex area (Rs = 0.43).

Data conclusions: Feature-tracking and 4D flow MRI revealed improved systolic and diastolic LV function during long-term follow-up after ASA. The diastolic LV vortex was associated with the combined parameters of LV volume and deformation. Comprehensive cardiac MRI may help understand the beneficial effects of ASA.

Evidence level: 3.

Technical efficacy: Stage 5.

背景:对血流动力学、支持形态和变形的详细评估可能有助于揭示肥厚性阻塞性心肌病(HOCM)的病理生理学和酒精室间隔消融(ASA)造成的变化。目的:探讨HOCM患者ASA前后长期随访期间心脏总容积、心肌变形及血流动力学特征。研究类型:回顾性。研究对象:23例HOCM患者(68.1±8.6岁,21.7%男性)在ASA前后行MRI检查。场强/序列:3T,采用稳态采集的二维快速成像,反演恢复制备的快速梯度回波序列,以及电影和时间分辨的三维电影相对比(4D流)MRI。评估:全脑左室(LV)容量,心肌特征跟踪MRI峰值应变和应变率,4D血流MRI血流动力学特征。统计检验:配对t检验和Wilcoxon符号秩检验分别比较正态分布和非正态分布的数据。适当时,使用卡方检验或费雪精确检验来比较分类数据。Pearson’s或Spearman’s相关系数评估相关性。结果:在LV长轴图像中,ASA后整体径向应变显著增加(16.6%±5.8% vs. 20.1%±6.8%),整体纵向应变显著降低(-10.5%±3.2% vs. -12.1%±3.5%)。ASA后舒张期左室前涡面积明显增大(2256.1 [703.6,4038.4]vs. 3826.1 [1914.3, 4820.1] mm2)。左室长轴图像的左室舒张末期容积指数、总周向应变和左室径向峰值应变率的倍增显示,左室舒张期前涡面积与左室舒张期前涡面积有显著相关性(Rs = 0.43)。数据结论:在ASA后的长期随访中,特征跟踪和4D血流MRI显示左室收缩和舒张功能有所改善。左室舒张期涡与左室容积和左室变形的综合参数有关。全面的心脏MRI可能有助于了解ASA的有益作用。证据等级:3。技术功效:第5阶段。
{"title":"Alcohol Septal Ablation in Hypertrophic Obstructive Cardiomyopathy: Long-Term Follow-Up of Deformations and Hemodynamics.","authors":"Kenichiro Suwa, Kazuto Ohno, Terumori Satoh, Ryota Sato, Keisuke Iguchi, Yuichiro Maekawa","doi":"10.1002/jmri.70156","DOIUrl":"https://doi.org/10.1002/jmri.70156","url":null,"abstract":"<p><strong>Background: </strong>A detailed evaluation of hemodynamics, supportive morphology, and deformation may help uncover the pathophysiology of hypertrophic obstructive cardiomyopathy (HOCM) and the changes wrought by alcohol septal ablation (ASA).</p><p><strong>Purpose: </strong>To investigate the global cardiac volume, myocardial deformation, and hemodynamic characteristics before and during long-term follow-up after ASA in patients with HOCM.</p><p><strong>Study type: </strong>Retrospective.</p><p><strong>Subjects: </strong>Twenty-three patients (68.1 ± 8.6 years, 21.7% male) with HOCM who underwent MRI before and after ASA.</p><p><strong>Field strength/sequence: </strong>A 3T, Two-dimensional fast imaging employing steady-state acquisition, inversion recovery-prepared fast gradient echo sequences, and cine and time-resolved three-dimensional cine phase-contrast (4D flow) MRI.</p><p><strong>Assessment: </strong>Global left ventricular (LV) volume by cine, peak strain, and strain rate by myocardial feature-tracking MRI, and hemodynamic characteristics by 4D flow MRI.</p><p><strong>Statistical tests: </strong>Paired t-test and Wilcoxon signed-rank test compared normally and nonnormally distributed data, respectively. Chi-squared or Fisher's exact tests were used to compare categorical data, as appropriate. Pearson's or Spearman's correlation coefficient evaluated the correlations. Statistical significance was set at q ≤ 0.10 or p < 0.05.</p><p><strong>Results: </strong>In LV long-axis images, the global radial strain increased significantly (16.6% ± 5.8% vs. 20.1% ± 6.8%), whereas the global longitudinal strain decreased significantly after ASA (-10.5% ± 3.2% vs. -12.1% ± 3.5%). The diastolic LV anterior vortex area increased significantly after ASA (2256.1 [703.6, 4038.4] vs. 3826.1 [1914.3, 4820.1] mm<sup>2</sup>). Multiplication of the LV end-diastolic volume index, global circumferential strain, and diastolic radial peak strain rate in LV long-axis images revealed a significant correlation with the diastolic LV anterior vortex area (Rs = 0.43).</p><p><strong>Data conclusions: </strong>Feature-tracking and 4D flow MRI revealed improved systolic and diastolic LV function during long-term follow-up after ASA. The diastolic LV vortex was associated with the combined parameters of LV volume and deformation. Comprehensive cardiac MRI may help understand the beneficial effects of ASA.</p><p><strong>Evidence level: </strong>3.</p><p><strong>Technical efficacy: </strong>Stage 5.</p>","PeriodicalId":16140,"journal":{"name":"Journal of Magnetic Resonance Imaging","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145355024","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiac Involvement After Exertional Heatstroke: Short-Term Cardiac MRI Follow-Up Study. 心力中暑后心脏受累:短期心脏MRI随访研究。
IF 3.5 2区 医学 Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2025-10-20 DOI: 10.1002/jmri.70157
Jun Zhang, Xiang Kong, Li Qi, Shutian Xu, Tongyuan Liu, Jun Cai, Song Luo, Long Jiang Zhang

Background: Myocardial involvement is a major manifestation of exertional heatstroke (EHS), yet its short-term clinical outcome remains unclear.

Purpose: To assess serial cardiac left ventricular structural and functional changes using baseline and 3-month cardiac MRI.

Study type: Prospective.

Population: A total of 41 participants (median age, 21 years; IQR, 20-23 years) hospitalized for EHS and 27 age-, sex-, and training-matched healthy controls (HCs).

Field strength/sequence: Fast imaging employing steady-state acquisition (cine imaging), saturation methods using adaptive recovery times (native T1, extracellular volume [ECV]), phase-sensitive inversion-recovery gradient recalled echo (late gadolinium enhancement [LGE]), and multi-echo fast spin echo (T2) sequences at 3.0 T.

Assessment: Longitudinal comparisons were performed within the EHS group (baseline vs. 3-month follow-up), and cross-sectional comparisons were performed between patients and HCs. Cardiac symptoms (chest pain, dyspnea, palpitations, and syncope) at follow-up were recorded using standardized questionnaires.

Statistical tests: Paired sample t-test, independent sample t-test, analysis of variance, Kendall's τ-b. A p value < 0.05 was considered significant.

Results: Significant improvements were observed in native T1 (1492 ± 52 ms vs. 1521 ± 57 ms), ECV (23.4% ± 1.7% vs. 24.3% ± 1.8%), T2 (45.9 ± 2.2 ms vs. 47.3 ± 2.3 ms), and 2D global longitudinal strain (-16.7% ± 1.6% vs. -15.8% ± 1.1%) at 3 months follow-up compared to baseline parameters in the EHS cohort. However, native T1 (1492 ± 52 ms vs. 1456 ± 26 ms) and ECV (23.4% ± 1.7% vs. 20.6% ± 1.6%) at follow-up were significantly higher in EHS than in HCs. At 3-month follow-up, native T1, ECV, and LGE presence were associated with cardiac symptoms (Kendall's τ-b = -0.430, -0.447, and -0.398, respectively).

Data conclusion: This study demonstrated persistently elevated native T1 and ECV at 3 months following EHS, despite partial improvement. Those with residual abnormalities should not be cleared for unrestricted training.

Evidence level: 2.

Technical efficacy: Stage 2.

背景:心肌受累是劳累性中暑(EHS)的主要表现,但其短期临床结果尚不清楚。目的:通过基线和3个月心脏MRI评估左心室结构和功能的变化。研究类型:前瞻性。人群:共有41名参与者(中位年龄21岁;IQR为20-23岁)因EHS住院,27名年龄、性别和训练匹配的健康对照(hc)。场强/序列:采用稳态采集(电影成像)的快速成像,采用自适应恢复时间(原生T1,细胞外体积[ECV])的饱和方法,相敏反转恢复梯度回忆回波(晚期钆增强[LGE]),以及3.0 T的多回声快速自旋回波(T2)序列。评估:在EHS组内进行纵向比较(基线与3个月随访),并在患者和hc之间进行横断面比较。使用标准化问卷记录随访时的心脏症状(胸痛、呼吸困难、心悸和晕厥)。统计检验:配对样本t检验、独立样本t检验、方差分析、肯德尔τ-b。结果:与EHS队列的基线参数相比,3个月随访时,原生T1(1492±52 ms vs 1521±57 ms)、ECV(23.4%±1.7% vs 24.3%±1.8%)、T2(45.9±2.2 ms vs 47.3±2.3 ms)和2D全局纵向应变(-16.7%±1.6% vs -15.8%±1.1%)均有显著改善。然而,随访时EHS患者的原生T1(1492±52 ms vs 1456±26 ms)和ECV(23.4%±1.7% vs 20.6%±1.6%)明显高于hc患者。在3个月的随访中,原生T1、ECV和LGE的存在与心脏症状相关(Kendall τ-b分别= -0.430、-0.447和-0.398)。数据结论:本研究显示,尽管局部改善,但在EHS后3个月,原生T1和ECV持续升高。有残留异常的不应清除无限制训练。证据等级:2。技术功效:第二阶段。
{"title":"Cardiac Involvement After Exertional Heatstroke: Short-Term Cardiac MRI Follow-Up Study.","authors":"Jun Zhang, Xiang Kong, Li Qi, Shutian Xu, Tongyuan Liu, Jun Cai, Song Luo, Long Jiang Zhang","doi":"10.1002/jmri.70157","DOIUrl":"https://doi.org/10.1002/jmri.70157","url":null,"abstract":"<p><strong>Background: </strong>Myocardial involvement is a major manifestation of exertional heatstroke (EHS), yet its short-term clinical outcome remains unclear.</p><p><strong>Purpose: </strong>To assess serial cardiac left ventricular structural and functional changes using baseline and 3-month cardiac MRI.</p><p><strong>Study type: </strong>Prospective.</p><p><strong>Population: </strong>A total of 41 participants (median age, 21 years; IQR, 20-23 years) hospitalized for EHS and 27 age-, sex-, and training-matched healthy controls (HCs).</p><p><strong>Field strength/sequence: </strong>Fast imaging employing steady-state acquisition (cine imaging), saturation methods using adaptive recovery times (native T1, extracellular volume [ECV]), phase-sensitive inversion-recovery gradient recalled echo (late gadolinium enhancement [LGE]), and multi-echo fast spin echo (T2) sequences at 3.0 T.</p><p><strong>Assessment: </strong>Longitudinal comparisons were performed within the EHS group (baseline vs. 3-month follow-up), and cross-sectional comparisons were performed between patients and HCs. Cardiac symptoms (chest pain, dyspnea, palpitations, and syncope) at follow-up were recorded using standardized questionnaires.</p><p><strong>Statistical tests: </strong>Paired sample t-test, independent sample t-test, analysis of variance, Kendall's τ-b. A p value < 0.05 was considered significant.</p><p><strong>Results: </strong>Significant improvements were observed in native T1 (1492 ± 52 ms vs. 1521 ± 57 ms), ECV (23.4% ± 1.7% vs. 24.3% ± 1.8%), T2 (45.9 ± 2.2 ms vs. 47.3 ± 2.3 ms), and 2D global longitudinal strain (-16.7% ± 1.6% vs. -15.8% ± 1.1%) at 3 months follow-up compared to baseline parameters in the EHS cohort. However, native T1 (1492 ± 52 ms vs. 1456 ± 26 ms) and ECV (23.4% ± 1.7% vs. 20.6% ± 1.6%) at follow-up were significantly higher in EHS than in HCs. At 3-month follow-up, native T1, ECV, and LGE presence were associated with cardiac symptoms (Kendall's τ-b = -0.430, -0.447, and -0.398, respectively).</p><p><strong>Data conclusion: </strong>This study demonstrated persistently elevated native T1 and ECV at 3 months following EHS, despite partial improvement. Those with residual abnormalities should not be cleared for unrestricted training.</p><p><strong>Evidence level: </strong>2.</p><p><strong>Technical efficacy: </strong>Stage 2.</p>","PeriodicalId":16140,"journal":{"name":"Journal of Magnetic Resonance Imaging","volume":" ","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145337080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Magnetic Resonance Imaging
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1